AccuStem Sciences Limited
ACMSY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$4 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$4 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.18 | -0.34 | -0.067 |
| % Growth | 27.8% | 47.1% | -406.7% | – |
| Operating Cash Flow | -$1 | – | -$2 | – |
| Capital Expenditures | $0 | – | $0 | – |
| Free Cash Flow | -$1 | – | -$2 | – |